LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Twist Bioscience Corp

Closed

SectorHealthcare

31.88 -2.78

Overview

Share price change

24h

Current

Min

31.52

Max

33.19

Key metrics

By Trading Economics

Income

-48M

-27M

Sales

3M

99M

EPS

-0.45

Profit margin

-27.41

Employees

979

EBITDA

3.2M

-21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.92% upside

Market Stats

By TradingEconomics

Market Cap

101M

2B

Previous open

34.66

Previous close

31.88

News Sentiment

By Acuity

50%

50%

187 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

11 Dec 2025, 23:58 UTC

Acquisitions, Mergers, Takeovers

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

11 Dec 2025, 23:56 UTC

Earnings

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

11 Dec 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

11 Dec 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

11 Dec 2025, 21:50 UTC

Earnings

Costco Same-Store Sales, Membership Fees Rose in 1Q

11 Dec 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

11 Dec 2025, 23:44 UTC

Market Talk

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

11 Dec 2025, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

11 Dec 2025, 23:31 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11 Dec 2025, 22:48 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

11 Dec 2025, 22:35 UTC

Earnings

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

11 Dec 2025, 22:30 UTC

Earnings

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

11 Dec 2025, 22:09 UTC

Acquisitions, Mergers, Takeovers

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

11 Dec 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

11 Dec 2025, 22:05 UTC

Earnings

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11 Dec 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

11 Dec 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

11 Dec 2025, 21:39 UTC

Earnings

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

11 Dec 2025, 21:39 UTC

Earnings

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

11 Dec 2025, 21:38 UTC

Earnings

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

11 Dec 2025, 21:37 UTC

Earnings

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

11 Dec 2025, 21:37 UTC

Market Talk

Broadcom Sees AI Revenue Doubling -- Market Talk

11 Dec 2025, 21:34 UTC

Acquisitions, Mergers, Takeovers

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

11 Dec 2025, 21:29 UTC

Acquisitions, Mergers, Takeovers

Dexus Aiming for Long-Term Holding of A$50M in Fund

11 Dec 2025, 21:28 UTC

Market Talk

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

11 Dec 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus Expects to Introduce Additional Third-Party Equity in FY26

11 Dec 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Dexus: Third Party Investors to Contribute Remainder

11 Dec 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

11 Dec 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

11 Dec 2025, 21:25 UTC

Acquisitions, Mergers, Takeovers

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

15.92% upside

12 Months Forecast

Average 38 USD  15.92%

High 42 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

187 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat